These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 23851493)

  • 1. The immune network in pancreatic cancer development and progression.
    Wörmann SM; Diakopoulos KN; Lesina M; Algül H
    Oncogene; 2014 Jun; 33(23):2956-67. PubMed ID: 23851493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrophages and pancreatic ductal adenocarcinoma.
    Habtezion A; Edderkaoui M; Pandol SJ
    Cancer Lett; 2016 Oct; 381(1):211-6. PubMed ID: 26708507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of the immune reaction to pancreatic cancer from inception to invasion.
    Clark CE; Hingorani SR; Mick R; Combs C; Tuveson DA; Vonderheide RH
    Cancer Res; 2007 Oct; 67(19):9518-27. PubMed ID: 17909062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCL17 and ICAM2 are associated with a potential anti-tumor immune response in early intraepithelial stages of human pancreatic carcinogenesis.
    Hiraoka N; Yamazaki-Itoh R; Ino Y; Mizuguchi Y; Yamada T; Hirohashi S; Kanai Y
    Gastroenterology; 2011 Jan; 140(1):310-21. PubMed ID: 20955708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically induced pancreatic adenocarcinoma is highly immunogenic and causes spontaneous tumor-specific immune responses.
    Garbe AI; Vermeer B; Gamrekelashvili J; von Wasielewski R; Greten FR; Westendorf AM; Buer J; Schmid RM; Manns MP; Korangy F; Greten TF
    Cancer Res; 2006 Jan; 66(1):508-16. PubMed ID: 16397267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory cytokines in human pancreatic cancer.
    Roshani R; McCarthy F; Hagemann T
    Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibition of the p38 alternative activation pathway in infiltrating T cells inhibits pancreatic cancer progression.
    Alam MS; Gaida MM; Bergmann F; Lasitschka F; Giese T; Giese NA; Hackert T; Hinz U; Hussain SP; Kozlov SV; Ashwell JD
    Nat Med; 2015 Nov; 21(11):1337-43. PubMed ID: 26479921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-Derived Myeloid Cell Chemoattractants and T Cell Exclusion in Pancreatic Cancer.
    Vonderheide RH; Bear AS
    Front Immunol; 2020; 11():605619. PubMed ID: 33304355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cells and their role in pancreatic cancer.
    Pergamo M; Miller G
    Cancer Gene Ther; 2017 Mar; 24(3):100-105. PubMed ID: 27910857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage PI3Kγ Drives Pancreatic Ductal Adenocarcinoma Progression.
    Kaneda MM; Cappello P; Nguyen AV; Ralainirina N; Hardamon CR; Foubert P; Schmid MC; Sun P; Mose E; Bouvet M; Lowy AM; Valasek MA; Sasik R; Novelli F; Hirsch E; Varner JA
    Cancer Discov; 2016 Aug; 6(8):870-85. PubMed ID: 27179037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell programming in pancreatic adenocarcinoma: a review.
    Seo YD; Pillarisetty VG
    Cancer Gene Ther; 2017 Mar; 24(3):106-113. PubMed ID: 27910859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The desmoplastic stroma plays an essential role in the accumulation and modulation of infiltrated immune cells in pancreatic adenocarcinoma.
    Tjomsland V; Niklasson L; Sandström P; Borch K; Druid H; Bratthäll C; Messmer D; Larsson M; Spångeus A
    Clin Dev Immunol; 2011; 2011():212810. PubMed ID: 22190968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevailing role of contact guidance in intrastromal T-cell trapping in human pancreatic cancer.
    Hartmann N; Giese NA; Giese T; Poschke I; Offringa R; Werner J; Ryschich E
    Clin Cancer Res; 2014 Jul; 20(13):3422-33. PubMed ID: 24763614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Immunological Glance on Pancreatic Ductal Adenocarcinoma.
    Melzer MK; Arnold F; Stifter K; Zengerling F; Azoitei N; Seufferlein T; Bolenz C; Kleger A
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity.
    Stromnes IM; Brockenbrough JS; Izeradjene K; Carlson MA; Cuevas C; Simmons RM; Greenberg PD; Hingorani SR
    Gut; 2014 Nov; 63(11):1769-81. PubMed ID: 24555999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Manipulation of Host Physiology: Lessons from Pancreatic Cancer.
    Zambirinis CP; Miller G
    Trends Mol Med; 2017 May; 23(5):465-481. PubMed ID: 28400243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hedgehog signaling and pancreatic tumor development.
    Lauth M; Toftgård R
    Adv Cancer Res; 2011; 110():1-17. PubMed ID: 21704226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Innate and adaptive immune pathways to tolerance.
    Thornton CA; Morgan G
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 64():45-57; discussion 57-61, 251-7. PubMed ID: 19710514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells.
    Vernon PJ; Loux TJ; Schapiro NE; Kang R; Muthuswamy R; Kalinski P; Tang D; Lotze MT; Zeh HJ
    J Immunol; 2013 Feb; 190(3):1372-9. PubMed ID: 23269246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic glycolytic reprogramming effects on dendritic cells in pancreatic ductal adenocarcinoma.
    Zhang B; Ohuchida K; Tsutsumi C; Shimada Y; Mochida Y; Oyama K; Iwamoto C; Sheng N; Fei S; Shindo K; Ikenaga N; Nakata K; Oda Y; Nakamura M
    J Exp Clin Cancer Res; 2024 Sep; 43(1):271. PubMed ID: 39343933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.